LIDDS AB - LIDDS kompositionspatent godkänt i Europa. Bolagsanalys Redeye 9 juli 2015. LIDDS AB: Klinisk prövning med Liproca Depot slutförd enligt plan. LIDDS med artikel i SVD. Ytterligare ett patent för Liproca Depot godkänt i Mexico. Nytt patent kopplat till Liproca Depot godkänt i Mexiko. LIDDS presentation - Erik Penser Bolagsdag 21 maj 2015. LIDDS med vd Monica Walter deltar på E Pensers bolagsdag den 21 maj kl 17:00. LIDDS med artikel i DI.
http://www.lidds.se/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
16x16
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
22
SITE IP
62.109.34.30
LOAD TIME
0 sec
SCORE
6.2
Hem | lidds.se Reviews
https://lidds.se
LIDDS AB - LIDDS kompositionspatent godkänt i Europa. Bolagsanalys Redeye 9 juli 2015. LIDDS AB: Klinisk prövning med Liproca Depot slutförd enligt plan. LIDDS med artikel i SVD. Ytterligare ett patent för Liproca Depot godkänt i Mexico. Nytt patent kopplat till Liproca Depot godkänt i Mexiko. LIDDS presentation - Erik Penser Bolagsdag 21 maj 2015. LIDDS med vd Monica Walter deltar på E Pensers bolagsdag den 21 maj kl 17:00. LIDDS med artikel i DI.
lidds.se
Investerare
http://www.lidds.se/index.php/investerare
LIDDS AB (publ) Org nr: 556580-2856, Virdings allé 32B, 754 50 UPPSALA, www.lidds.se. Bolaget har sitt säte i Uppsala.
Medicinskt behov
http://www.lidds.se/index.php/medicinskt-behov
Valet av behandlingsalternativ görs utifrån kunskap om effekter på sjukdomen, biverkningspanorama, påverkan på livskvalitet, ansvarig doktors erfarenheter och preferenser, ålder och allmäntillstånd hos patienten. För patienter som nyligen diagnosticerats med prostatacancer är behandlingsalternativen vanligtvis beroende av sjukdomens stadium och spridning samt patientens sannolika kvarvarande livslängd. Ofta är det de olika riskerna för biverkningar som avgör valet av den inledande behandlingen...
Prostatacancer
http://www.lidds.se/index.php/medicinskt-behov/prostata-cancer
LIDDS AB (publ) Org nr: 556580-2856, Virdings allé 32B, 754 50 UPPSALA, www.lidds.se. Bolaget har sitt säte i Uppsala.
Bolagsbeskrivning
http://www.lidds.se/index.php/investerare/bolagsbeskrivning
LIDDS AB (publ) Org nr: 556580-2856, Virdings allé 32B, 754 50 UPPSALA, www.lidds.se. Bolaget har sitt säte i Uppsala.
Bolagsordning
http://www.lidds.se/index.php/investerare/bolagsordning
Bolagsordning för Lidds ab, org. nr. 556580-2856. An. Tagen på årsstämman 22 april 2016. Bolagets firma är LIDDS AB. Bolaget är publikt (publ). Bolaget har sitt säte i Uppsala. Bolaget skall bedriva utveckling och kommersialisering av lokalt implanterade medicinleveranssystem och idka därmed förenligt verksamhet. Aktiekapitalet utgör lägst 500.000 kronor och högst 2.000.000 kronor. Antalet aktier skall vara lägst 9.500.000 stycken och högst 38.000.000 stycken. 6 Styrelse och revisorer. Prövning av om stä...
TOTAL PAGES IN THIS WEBSITE
20
The Liproca® Product
http://www.liddspharma.com/index.php/the-liproca-product
Problems With Current Treatment. The Liproca Depot Product. It’s a well-known fact that current treatments of prostate cancer have serious adverse effects on patient’s quality of life. We wanted to develop a novel product to effectively treat the cancer while minimizing the side-effects. The Product - A first-in-class local treatment of prostate cancer. The product is delivered pre-filled in a sterile container/syringe, which also acts as mixing equipment of the paste prior to injection. Local administra...
User remind
http://www.liddspharma.com/index.php/joomla-pages-ii/user-remind
Problems With Current Treatment. Please enter the email address associated with your User account. Your username will be emailed to the email address on file. Email Address: *. LIDDS AB, Kullagatan 8, SE-252 20 Helsingborg, Sweden tel: 46 (0) 737 07 09 22 mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it. Log in with Facebook. Confirm Password: *. Email Address: *. Confirm email Address: *.
New promising clinical data
http://www.liddspharma.com/index.php/lidds-news/88-new-promising-clinical-data
Problems With Current Treatment. New promising clinical data. New promising clinical data. Published on Friday, 21 March 2014 15:44. The results from the recently finalized clinical phase IIa study with Liproca Depot in patients with localized prostate cancer (scheduled for prostatectomy) will be presented by Prof. Teuvo Tammela, Tampere University Hospital, at the EAU-meeting in Stockholm, Sweden on April 14, 2014. Stone NN, Clejan SJ. J Androl. 1991;12(6): 376-80. Please follow the link. LIDDS AB, Kull...
Company Presentations
http://www.liddspharma.com/index.php/the-company/company-presentations
Problems With Current Treatment. This film about LIDDS was broadcasted on CNBC Europe. And covers different aspects of Liproca and issues surrounding the project. LIDDS AB, Kullagatan 8, SE-252 20 Helsingborg, Sweden tel: 46 (0) 737 07 09 22 mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Hormonal Therapy
http://www.liddspharma.com/index.php/medical-need-main-menu/hormonal-therapy
Problems With Current Treatment. Nevertheless, in early prostate cancer there has been an enhanced prescription of oral antiandrogens during the last 5 10 years. This prescription trend is expected to continue as a consequence of the increased use of plasma PSA as a screening tool that will lead to more patients diagnosed with early prostate cancer. The most commonly used oral antiandrogen therapy today is bicalutamide (Casodex. From AstraZeneca and flutamide (Eulexin.
Thomas Uhlin appointed new CEO of LIDDS
http://www.liddspharma.com/index.php/lidds-news/92-thomas-uhlin-appointed-new-ceo-of-lidds
Problems With Current Treatment. Thomas Uhlin appointed new CEO of LIDDS. Thomas Uhlin appointed new CEO of LIDDS. Published on Tuesday, 16 September 2014 13:59. LIDDS AB, Kullagatan 8, SE-252 20 Helsingborg, Sweden tel: 46 (0) 737 07 09 22 mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it. Log in with Facebook. Confirm Password: *. Email Address: *. Confirm email Address: *.
News
http://www.liddspharma.com/index.php/lidds-news
Problems With Current Treatment. Monica Wallter appointed new CEO of LIDDS. Thomas Uhlin has for personal reasons decided to leave his position as CEO. The Board has appointed Monica Wallter new CEO and she will assume her new role March 16.th. Monica Wallter has many years of experience in senior positions in listed companies. She has been CEO for Ellen AB and Probi AB and has held senior positions at Pharmacia. Thomas Uhlin appointed new CEO of LIDDS. Thomas Uhlin s broad experience in leading developm...
LIDDS approved for listing on NASDAQ OMX First North. First day of trading is scheduled for 31 July 2014
http://www.liddspharma.com/index.php/lidds-news/90-lidds-approved-for-listing-on-nasdaq-omx-first-north-first-day-of-trading-i-scheduled-for-31-july-2014
Problems With Current Treatment. LIDDS approved for listing on NASDAQ OMX First North. First day of trading is scheduled for 31 July 2014. LIDDS approved for listing on NASDAQ OMX First North. First day of trading is scheduled for 31 July 2014. Published on Monday, 23 June 2014 15:06. LIDDS approved for listing on NASDAQ OMX First North. First day of trading is scheduled for 31 July 2014. Log in with Facebook. Confirm Password: *. Email Address: *. Confirm email Address: *.
Treatment Alternatives
http://www.liddspharma.com/index.php/medical-need-main-menu/treatment-alternatives
Problems With Current Treatment. The choice of treatment depends on the stage and grade of the disease and the patient’s life expectancy. Broadly, patients with localized early stage PC and long life expectancy are offered radiotherapy or surgery. The care of other patients often follows a policy of observation and/or hormonal therapy.
Monica Wallter appointed new CEO of LIDDS
http://www.liddspharma.com/index.php/lidds-news/93-monica-wallter-appointed-new-ceo-of-lidds
Problems With Current Treatment. Monica Wallter appointed new CEO of LIDDS. Monica Wallter appointed new CEO of LIDDS. Published on Friday, 20 February 2015 19:41. Thomas Uhlin has for personal reasons decided to leave his position as CEO. The Board has appointed Monica Wallter new CEO and she will assume her new role March 16.th. Monica Wallter has many years of experience in senior positions in listed companies. She has been CEO for Ellen AB and Probi AB and has held senior positions at Pharmacia.
TOTAL LINKS TO THIS WEBSITE
22
liddotel.com
The domain liddotel.com is for sale. To purchase, call Afternic.com at 1 781-373-6847 or 855-201-2286. Click here for more details.
$pillYourGutsOut!
Everyday he waits for his owner. Permalink (128,435 notes). X3cdiv id= 'tumblr video container 170377092217 ' class= 'tumblr video container ' style= 'width:500px;height:281px; ' x3e x3ciframe src= 'https:/ www.tumblr.com/video/liddothugmayra/170377092217/500/ ' style= 'display:block;background-color:transparent;overflow:hidden ' class= 'embed iframe tumblr video iframe ' scrolling= 'no ' frameBorder= '0 ' data-can-gutter data-can-resize data-width= '500 ' data-height= '281 ' width= '500 ' height...
gee. . .
A tiny, unique 16 year old w. a big heart . Paradise valley high school. Follow me c;. Add me on fb. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Kim and North in Vogue. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Photo Post Sun, Mar. 23, 2014. Video Post Sun, Mar. 23, 2014.
Music Blog of Liddousmusic - Plusieurs artistes en fait :p - Skyrock.com
Plusieurs artistes en fait :p. Voilà, c'est juste un blog pour mettre les musiques que j'aime. (J'ai vraiment mis un titre pourris, mais c'était pas volontaire :p) Vous trouverez de tous les styles de musique : métal, rock, celtic, classique, BO de films, jazz, soul, latino, techno, electro. 04/06/2008 at 9:52 AM. 15/01/2009 at 10:51 AM. Pulp Fiction Soundtrack / Girl, You'll Be. Girl You'll be a woman soon I love you. Powertrip / See You in Hell (1998). Subscribe to my blog! Plusieurs artistes en fait :p.
"Life"
Upgrade to paid account! This is what happens when I get bored. Jul 8th, 2010. Why am I apparently incapable of getting my shit together? At least I finally did the dishes. Not that there was much of anything there, but I was running low on mugs. There's a bunch of stuff I want to do. I'd like to make cookies. I'd like to set up my xbox. I always end up sitting on the couch watching the news though. May 28th, 2010 at 3:12 PM. Past entries either flocked or privatized. It's time for a fresh start.
Hem
LIDDS AB - LIDDS kompositionspatent godkänt i Europa. Bolagsanalys Redeye 9 juli 2015. LIDDS AB: Klinisk prövning med Liproca Depot slutförd enligt plan. LIDDS med artikel i SVD. Ytterligare ett patent för Liproca Depot godkänt i Mexico. Nytt patent kopplat till Liproca Depot godkänt i Mexiko. LIDDS presentation - Erik Penser Bolagsdag 21 maj 2015. LIDDS med vd Monica Walter deltar på E Pensers bolagsdag den 21 maj kl 17:00. LIDDS med artikel i DI.
Music Blog of lidds - lids - Skyrock.com
Ag3 : 15 ans De BetiSe mdr. Ville : Les Ulis Mon Pote. KarTier : EL chantreine. Celiib Ou PRiiiS : heuu Celiib. AdreSSe Msn : Oualid919@hot.fr. ET pour le resTe Baaa Pren mOn adreSSe et Jte Direiii . :) (l). Les ULiiS 91940 siiisiii (91). 23/01/2009 at 2:39 PM. 12/10/2009 at 11:15 AM. Instru Pour les mec del chantreiine! Subscribe to my blog! Add to my blog. Instru Pour les mec del chantreiine! Brui de gun asuuréé! Add to my blog. Instru Pour les mec del chantreiine! Brui de gun asuuréé! Don't forget tha...
Liddiard Scaffolding are NASC Commercial, Industrial, Domestic Scaffolders
Welcome to Liddiard Scaffolding Limited. Telephone us 01730 710 578. Have a look at our Job Vacancies. Check out all the latest news on Rough Runner. Looking for a quote? New in 2017, Full NASC Members. Scaffold hire for industrial customers. Scaffolding for commercial customers. Domestic and other scaffolding services. For your free quotation or to arrange a site survey click our Quote Me button. Get in contact with us, one of our friendly team will be happy to answer any questions.
liddsonline-birthdaygreetings.blogspot.com
BIRTHDAY GREETINGS
Tuesday, 8 May 2007. Sunday, 6 May 2007. TO SUM UP THE GAME. Plenty of names in the frame for the Man of the Match. But the casting vote went for "Paul Edwards". Second half "Danny Brooks" was brought down in the box. "Ryan Fice" stepped up and beat the experience of the visiting keeper "Andy Meads" to score from the spot. Johny Morris" was on hand to tap home from close in, after good work by "Lee Doel" for our second goal. PARKWAY ACTION V TAVY. Subscribe to: Posts (Atom). TO SUM UP THE GAME.
liddsonline
PLYMOUTH PARKWAY FOOTBALL CLUB. Sunday, 21 June 2015. Posted by liddsonline at 20:55. A popular choice by the squad, it went to "Mike Landricombe". Posted by liddsonline at 20:39. This had to be a shared vote for the season, with level pegs for both players. "Andy Neale and Levi Landricombe". Posted by liddsonline at 20:35. THE SMILE SAYS IT ALL! Parkway Power Player for the season could not be a better choice,. Step up "Jamie Bass". Posted by liddsonline at 20:29. Posted by liddsonline at 20:24.
Lidds – An innovative drug delivery platform
NEWS & MEDIA. NEWS & MEDIA. Innovative drug delivery platform for the benefit of patients and pharma industry. LIDDS: NanoZolid with cutting edge STING agonist becomes a key project for LIDDS in immuno-oncology field. LIDDS presenterar bokslutskommuniké 2017. LIDDS: Liproca Depot effects on prostate cancer to be presented at the Paris Symposium for Magnetic Resonance in Medicine. LIDDS: Nyenburgh Holding invests 13,5 MSEK in a direct share issue. 2018-02-22 Year End Report 2017. 000 ( 0.00%). LIDDS (Loca...
